AI MARKET SCANNING

Spyre Therapeutics Inc

🏛️ NASDAQ 📁 Health Technology 🏭 Pharmaceuticals Major
AVG HISTORICAL GAP +0.13%
MAX GAP RECORD +9.99%
🔒 PRO INSTITUTIONAL AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡

SENTINEL HISTORICAL GAP VIEWER

// $SYRE
📊 1-YEAR TIMELINE (GAPS PLOTTED) 🔮 SIMULATE SETUP 🔒
Bullish Opening Gap Bearish Opening Gap T-1 Close Baseline

CATALYSTS & GAP HISTORY

Aug 04, 2026 Earnings Release 2026-08-04 (AFTER CLOSE)
+0.00%
May 05, 2026 Earnings Release 2026-05-05 (BEFORE OPEN)
+2.19%
Feb 19, 2026 Earnings Release 2026-02-19 (AFTER CLOSE)
+0.03%
Nov 04, 2025 Earnings Release 2025-11-04 (AFTER CLOSE)
+1.70%
Aug 05, 2025 Earnings Release 2025-08-05 (AFTER CLOSE)
+0.06%
May 07, 2025 Earnings Release 2025-05-07 (AFTER CLOSE)
-1.18%
Feb 27, 2025 Earnings Release 2025-02-27 (AFTER CLOSE)
+1.74%
Nov 07, 2024 Earnings Release 2024-11-07 (AFTER CLOSE)
-4.83%

VOLATILITY & GAP BIAS

AVG GAP MOVE 2.9%
Bullish Gaps (6)
Bearish Gaps (5)
Neutral / Flat (3)

QUANTITATIVE LIVE RADAR BLOTTER

Algorithmic execution stream for $SYRE

EXECUTIONS1 LOGS
STATUS🔒 ENCRYPTED
Execution Date Strategy & Setup Direction Execution Range Hold Time Net PnL
2026-10-29 🔒 PRO RADAR ••• x• $•••.•• → $•••.•• 1346m +4.13%
🔒 Real-Time Strategy Telemetry Protected

Exact execution levels, Trailing Stops, and live bot signals are reserved for PRO members.

UNLOCK LIVE RADAR ⚡

📖 Intelligence Summary

Spyre Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of next-generation human enzyme therapeutics as disruptive solutions for rare and other high-burden diseases. Its product, Pegzilarginase, is in a Phase 3 pivotal trial for the treatment of Arginase 1 Deficiency. The company was founded by George…

NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗